Condition | Anti- convulsants |
Anti- depressants |
Oral Drugs with Local Anesthetic Type Properties |
Opioids | Topical (Capsaicin) |
Intravenous Regional Sympathetic Blocks |
---|---|---|---|---|---|---|
Trigeminal neuralgia | Level I | No controlled trials | Level II | Level V | No controlled trials | Not applicable |
Peripheral nerve injury | No controlled trials | No controlled trials | Level II | No controlled trials | No controlled trials | No controlled trials |
Postherpetic neuralgia | Level II | Level II | Level II | Level II | Level II | No controlled trials |
Complex regional pain syndrome Type I | No controlled trials | No controlled trials | No controlled trials | No controlled trials | No controlled trials | Level III |
Diabetic neuropathy | Level I | Level I | Level II | Refer to comments in guidelines. | Level II | No controlled trials |
Pain after stroke | Level II | Level II | No controlled trials | No controlled trials | No controlled trials | No controlled trials |
Spinal cord injury | No controlled trials | No controlled trials | Level II | No controlled trials | No controlled trials | Not applicable |
Pain after mastectomy | No controlled trials | No controlled trials | No controlled trials | No controlled trials | Level II | Not applicable |